Author: super@dmin
-

The View From Unretirement: Should I retire? One man’s yearlong search for whether, how—or if — to retire
LA Times columnist Steve Lopez on what he learned interviewing retirees and never-retirers, as well as Mel Brooks and Norman Lear.
-

Peter Morici: Supply-side challenges frustrate the Fed and other central bankers
Central bankers look at the economy through a Keynesian lens that only targets demand
-

Bond Report: Benchmark Treasury stalled as traders await Fed decision
Market pricing in a 90% probability the Fed will announce at 2 p.m. Eastern that it is raising interest rates by 75 basis points to a range of 3.75% to 4.00%
-

Earnings Results: Shipping giant A.P. Moeller-Maersk says it’s clear that freight rates have peaked
Shipping giant A.P. Moeller-Maersk on Wednesday said it’s clear that freight rates have peaked as it produced another surge in third-quarter profit.
-

Kelley Blue Book: The 2022 Kia EV6 vs. the 2023 Volkswagen ID.4: which electric SUV is better?
The Volkswagen has a lot of practical traits and a clever user interface, but the Kia has it beat in range, power, and excitement.
-

Market Snapshot: U.S. stock futures rise in cautious trade ahead of Fed policy announcement
Central bank expected to hike rates by 75 basis points, but what it says about policy going forward should determine the market’s trajectory analysts say
-

NerdWallet: Don’t make this big mistake as your house hunt drags on
Your home search could easily outlast your preapproval letter. If you’re still on the hunt, you can relieve some pressure by renewing with your lender. Here’s how
-

Next Avenue: What neuroscientists have learned about rejuvenating the aging brain—and what you can do too
Some techniques that rejuvenate blood may hold promise for improving the performance of the aging human brain in the future. But there’s plenty we can do on our own.
-

Dow Jones Newswires: Aston Martin Lagonda global Q3 loss doubled; lowers 2022 guidance
The U.K. luxury-car maker said pretax loss for the three months was 225.9 million pounds ($259.4 million) compared with a loss of GBP97.9 million a year prior
-

Dow Jones Newswires: GSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
The British pharma major posted sales of 7.83 billion pounds ($8.99 billion) for the third quarter, up from GBP6.63 billion the year prior, and beating a company-provided consensus of GBP7.32 billion.